Jonathan Yong
Stock Analyst at UBS
(2.61)
# 2,234
Out of 5,012 analysts
97
Total ratings
60.38%
Success rate
11.25%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $4.96 | +0.81% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.70 | +11.11% | 4 | Aug 6, 2025 | |
| OSCR Oscar Health | Downgrades: Sell | $15 → $11 | $22.47 | -51.05% | 8 | Jul 15, 2025 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $27.91 | -10.43% | 2 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $7.96 | +50.75% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.39 | +82.23% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $13.12 | +98.17% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $57.97 | -75.85% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $64.88 | +47.97% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $13.04 | +145.40% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $19.40 | +441.24% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $125.20 | -36.10% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $279.62 | -17.39% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $8.37 | +222.58% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $156.65 | -36.16% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $750.13 | -40.01% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $3.19 | +276.18% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $6.04 | +1,058.94% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $15.92 | +6.78% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $203.26 | +72.19% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $27.23 | +248.88% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $4.74 | +79.32% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $24.02 | +70.69% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $4.76 | +257.14% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.13 | +171.57% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $83.00 | +2.41% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $181.89 | -19.73% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $38.42 | +175.90% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $209.70 | -25.13% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $307.14 | +19.82% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $295.25 | +115.07% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $77.12 | +51.71% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $17.60 | +70.45% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $437.57 | -31.90% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $204.83 | -53.62% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $363.66 | +36.12% | 1 | Oct 15, 2021 |
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $4.96
Upside: +0.81%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.70
Upside: +11.11%
Oscar Health
Jul 15, 2025
Downgrades: Sell
Price Target: $15 → $11
Current: $22.47
Upside: -51.05%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $27.91
Upside: -10.43%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $7.96
Upside: +50.75%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.39
Upside: +82.23%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $13.12
Upside: +98.17%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $57.97
Upside: -75.85%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $64.88
Upside: +47.97%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $13.04
Upside: +145.40%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $19.40
Upside: +441.24%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $125.20
Upside: -36.10%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $279.62
Upside: -17.39%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $8.37
Upside: +222.58%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $156.65
Upside: -36.16%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $750.13
Upside: -40.01%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $3.19
Upside: +276.18%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $6.04
Upside: +1,058.94%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $15.92
Upside: +6.78%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $203.26
Upside: +72.19%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $27.23
Upside: +248.88%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $4.74
Upside: +79.32%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $24.02
Upside: +70.69%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $4.76
Upside: +257.14%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.13
Upside: +171.57%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $83.00
Upside: +2.41%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $181.89
Upside: -19.73%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $38.42
Upside: +175.90%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $209.70
Upside: -25.13%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $307.14
Upside: +19.82%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $295.25
Upside: +115.07%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $77.12
Upside: +51.71%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $17.60
Upside: +70.45%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $437.57
Upside: -31.90%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $204.83
Upside: -53.62%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $363.66
Upside: +36.12%